CEPHALALGIA

Scope & Guideline

Pioneering Studies for Better Patient Outcomes

Introduction

Explore the comprehensive scope of CEPHALALGIA through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore CEPHALALGIA in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0333-1024
PublisherSAGE PUBLICATIONS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1981 to 2024
AbbreviationCEPHALALGIA / Cephalalgia
Frequency14 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

Cephalalgia is a leading journal focused on advancing the understanding, diagnosis, and treatment of headache disorders. It publishes a wide variety of research that contributes to the field, encompassing clinical trials, epidemiological studies, and explorations of underlying mechanisms.
  1. Migraine Research:
    The journal dedicates a significant focus to migraine, covering various aspects such as pathophysiology, treatment efficacy, and patient quality of life. Studies often explore the effects of new treatments, including CGRP monoclonal antibodies and other pharmacological interventions.
  2. Cluster Headache Studies:
    Research on cluster headaches is prominently featured, examining clinical characteristics, treatment responses, and the impact of these debilitating headaches on patients' lives. This includes both clinical trials and observational studies.
  3. Neurobiology and Pathophysiology:
    A substantial number of articles investigate the neurobiological mechanisms of headache disorders, including the roles of neuropeptides like CGRP, and the involvement of various brain regions during headache episodes.
  4. Comorbidities and Psychological Factors:
    The journal also explores the comorbidities associated with headache disorders, including psychological factors such as anxiety and depression, and how these affect treatment outcomes and patient experiences.
  5. Innovative Treatment Approaches:
    Cephalalgia highlights new treatment modalities and methodologies, including non-pharmacological interventions, lifestyle modifications, and the use of technology in headache management.
The journal has recently seen a rise in interest in several emerging themes within headache research, reflecting the latest advancements and ongoing discussions in the field. This section outlines these trending topics, which are likely to shape future research directions.
  1. CGRP Monoclonal Antibodies:
    There is a significant increase in studies focusing on CGRP monoclonal antibodies and their effects on migraine prevention and treatment. This trend highlights the growing importance of targeted therapies in managing migraine and cluster headaches.
  2. Real-World Evidence Studies:
    A surge in real-world evidence studies is evident, as researchers seek to understand how new treatments perform in everyday clinical settings, beyond the controlled environments of clinical trials.
  3. Psychological and Behavioral Aspects:
    Emerging research emphasizes the psychological aspects of headache disorders, exploring the relationship between migraine, mental health, and psychosocial factors, thus broadening the scope of headache research.
  4. Neuroimaging and Biomarkers:
    An increased focus on neuroimaging studies and the identification of biomarkers associated with migraine and headache disorders is trending, as researchers aim to better understand the underlying mechanisms and improve diagnostic accuracy.
  5. Telemedicine and Digital Health Interventions:
    The impact of telemedicine and digital health tools on headache management has gained momentum, particularly post-COVID-19, as the need for remote care options emerged, leading to innovative approaches in treatment delivery.

Declining or Waning

While the journal continues to thrive in various areas of headache research, certain topics have seen a decline in prominence over recent years. This section identifies these waning themes, which may reflect shifts in research priorities or advancements in understanding.
  1. Traditional Pharmacological Treatments:
    There has been a noticeable decline in studies focusing on traditional pharmacological treatments for migraines, such as triptans and older medications, as newer therapies, particularly CGRP inhibitors, gain favor and become the focus of research.
  2. Epidemiological Studies:
    Although epidemiological studies were once prevalent, there seems to be a reduction in the publication of large-scale prevalence studies, possibly due to the saturation of existing data and a shift towards more specific treatment efficacy research.
  3. Lifestyle and Dietary Interventions:
    Research focusing on lifestyle and dietary interventions for headache management has decreased, as the emphasis shifts towards pharmacological innovations and mechanistic studies.
  4. Acute Treatment Comparisons:
    Comparative studies of older acute treatments for migraines have become less common, as newer medications and treatment paradigms take precedence in research agendas.

Similar Journals

Journal of Stroke

Advancing Stroke Research for a Healthier Tomorrow
Publisher: KOREAN STROKE SOCISSN: 2287-6391Frequency: 3 issues/year

Journal of Stroke is a premier open-access journal published by the Korean Stroke Society, dedicated to advancing the understanding of stroke through cutting-edge research and innovative clinical practices. Since its inception in 2013, the journal has gained notable recognition in the fields of Cardiology and Cardiovascular Medicine and Neurology, reflecting its commitment to high-quality, peer-reviewed content, with rankings in the top quartiles (Q1) for both categories as of 2023. The journal’s impact is underscored by its Scopus rankings, placing it in the 92nd and 91st percentiles within its respective fields, thus serving as a vital resource for researchers, clinicians, and students seeking to enhance their knowledge and contribute to stroke research and treatment methodologies. The Journal of Stroke is strategically positioned in South Korea and fosters a global dialogue on stroke-related issues, reinforcing its role as a pivotal platform for disseminating vital findings that can influence both clinical practices and health policy.

Journal of Oral & Facial Pain and Headache

Innovating solutions for a pain-free future.
Publisher: QUINTESSENCE PUBLISHING CO INCISSN: 2333-0384Frequency: 4 issues/year

Journal of Oral & Facial Pain and Headache is a leading peer-reviewed publication dedicated to advancing the understanding and treatment of orofacial pain and headache disorders. Published by QUINTESSENCE PUBLISHING CO INC in the United States, this journal serves as a critical resource for researchers, clinicians, and students in the fields of anesthesiology, pain medicine, and dentistry. With a commendable impact factor reflected in its 2023 rankings—Q1 in Dental (miscellaneous) and Q2 in both Anesthesiology & Pain Medicine and Clinical Neurology—this journal highlights cutting-edge research and innovative practices aimed at improving patient outcomes. The journal's content is accessible with an Open Access option, ensuring that significant findings reach a broad audience. Since its inception in 1993 and through its evolving scope, Journal of Oral & Facial Pain and Headache remains an indispensable platform for scholarly exchange and professional development in its specialized field.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Pioneering research for a healthier future.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0954-691XFrequency: 12 issues/year

The EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, serves as a key platform for disseminating cutting-edge research in the fields of gastroenterology and hepatology since its inception in 1989. With its ISSN 0954-691X and E-ISSN 1473-5687, the journal has established a prominent reputation, as reflected in its 2023 rankings, placing it in Q2 for Gastroenterology and Q3 for Hepatology. It is ranked #75 out of 167 in gastroenterology and #39 out of 82 in hepatology according to Scopus, highlighting its importance in advancing knowledge and clinical practices. While it does not currently offer open access options, the journal remains essential for researchers, healthcare professionals, and students seeking to stay abreast of significant developments and innovations in digestive health. By providing rigorous peer-reviewed articles, the EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY continues to contribute to the understanding and treatment of gastrointestinal and liver diseases, making it a vital resource in the medical community.

Journal of Diabetes

Advancing diabetes research for a healthier tomorrow.
Publisher: WILEYISSN: 1753-0393Frequency: 12 issues/year

The Journal of Diabetes, published by WILEY, is a premier Open Access platform since 2022, dedicated to advancing knowledge in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 1753-0393 and an E-ISSN of 1753-0407, this journal provides a vital resource for researchers and practitioners looking to keep up with the latest findings and trends in diabetes management and treatment. As of 2023, it holds a commendable Q2 rating in its category and ranks #78 out of 244 in the Scopus classification, placing it in the 68th percentile, thus affirming its significance in the academic community. Covering a timeline from 2009 to 2024, the journal invites submissions that contribute to the understanding of diabetes pathophysiology, innovative therapies, and clinical practices, making it an essential read for anyone dedicated to improving patient outcomes in diabetes care.

NEUROLOGIC CLINICS

Advancing the frontiers of clinical neurology.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8619Frequency: 4 issues/year

NEUROLOGIC CLINICS, published by W B SAUNDERS CO-ELSEVIER INC, stands as a leading journal in the field of clinical neurology, boasting an impressive impact factor that reflects its significant contributions to neurological research and clinical practice. With an ISSN of 0733-8619 and E-ISSN of 1557-9875, this journal provides a critical platform for the dissemination of innovative research, case studies, and reviews focusing on various aspects of neurology, from diagnosis to treatment interventions. As part of its commitment to advancing the understanding of neurological disorders, NEUROLOGIC CLINICS is categorized in the Q2 quartile for Neurology (clinical) in 2023, indicating its robust standing within the academic community. It is recognized for its rigorous peer-review process and is indexed in Scopus, ranking #147 out of 400 in its field with a notable 63rd percentile. The journal, which dates back to 1983 and continues to publish vital findings up to 2024, is an invaluable resource for researchers, healthcare professionals, and students dedicated to enhancing their knowledge and clinical skills in neurology. Subscribe now to stay abreast of current advancements and expand your expertise in this dynamic field.

Advances in Rheumatology

Fostering collaboration for cutting-edge rheumatological advancements.
Publisher: BMCISSN: 2523-3106Frequency: 1 issue/year

Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.

Journal of Clinical Hypertension

Fostering Collaboration for Cardiovascular Excellence
Publisher: WILEYISSN: 1524-6175Frequency: 12 issues/year

Journal of Clinical Hypertension, published by WILEY, is a leading open-access journal focused on advancing the understanding and treatment of hypertension and related cardiovascular conditions. With an ISSN of 1524-6175 and an E-ISSN of 1751-7176, the journal provides a vital platform for researchers, healthcare professionals, and students alike to disseminate high-quality, peer-reviewed research. Since transitioning to open access in 2021, it has increased its reach and accessibility, ensuring critical information is available to a broader audience. The journal holds an impressive position in the Scopus ranks, nestled within the Q2 quartile across key disciplines including Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, and Internal Medicine, indicating a strong impact on the scientific community. With articles converging from 2001 to 2024, it not only highlights contemporary developments but also contributes to the ongoing dialogue in the field. Researchers are encouraged to submit their findings on hypertension, treatment methodologies, and epidemiology to further enhance the collective knowledge in this crucial area of health.

HEADACHE

Uniting Experts to Combat Headache Disorders
Publisher: WILEYISSN: 0017-8748Frequency: 10 issues/year

HEADACHE is a premier academic journal dedicated to advancing the study of headache disorders through innovative research and clinical insights. Published by WILEY, this influential journal has been serving the neurology community since its inception in 1961 and is recognized as a leader in its field, boasting an impressive Q1 ranking in both Neurology and Neurology (clinical) categories for 2023. With a robust Scopus ranking of #48 in clinical neurology and #26 in neuroscience, HEADACHE consistently publishes high-quality research that contributes to the understanding and treatment of headache disorders worldwide. Although it does not offer open access options, the journal remains accessible to a wide audience through various institutional subscriptions. It aims to provide a platform for researchers, healthcare professionals, and students to exchange ideas and develop new strategies for headache management, making it an essential resource for those dedicated to improving patient outcomes in this challenging area of healthcare.

Journal of Asthma and Allergy

Leading the way in allergy and asthma advancements.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-6965Frequency: 1 issue/year

The Journal of Asthma and Allergy, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing research in the fields of immunology, allergy, and pulmonary medicine. Since its inception in 2008, this journal has provided a vital platform for disseminating high-quality, peer-reviewed research that explores the complexities of asthma and allergy, allowing researchers, professionals, and students to access critical insights without subscription barriers. With an impressive impact factor reflected in its 2023 quartile rankings (Q2) in both Immunology and Allergy, as well as Pulmonary and Respiratory Medicine, the journal stands as a significant contributor to the scientific community, promoting innovative findings that support clinical practice and patient care. Based in New Zealand, the Journal of Asthma and Allergy continues to be at the forefront of research, from its dedication to publishing cutting-edge studies to fostering an inclusive academic discourse that spans the globe. Access to relevant articles is available online, ensuring that all stakeholders in these fields can stay informed and engaged.

Korean Journal of Pain

Shaping the future of anesthesia and pain management.
Publisher: KOREAN PAIN SOCISSN: 2005-9159Frequency: 4 issues/year

The Korean Journal of Pain is a distinguished open-access publication dedicated to advancing the field of pain management and anesthesia. Published by the Korean Pain Society, this journal has been a vital resource since 1988, contributing to significant advancements in clinical practice and research. With an impressive Q1 ranking in Anesthesiology and Pain Medicine, and a Scopus rank of #32 out of 136—placing it in the 76th percentile—this journal fosters high-quality scholarly communication among researchers and healthcare professionals. The journal's scope encompasses a wide range of topics related to pain, facilitating the exchange of knowledge crucial for both innovative research and effective clinical application. Located in Seoul, South Korea, it serves as an essential platform for publishing cutting-edge research, systematic reviews, and case reports, ensuring that the latest findings reach a global audience. Whether you are a researcher, clinician, or student, the Korean Journal of Pain is an indispensable resource for anyone dedicated to the study and treatment of pain.